175 related articles for article (PubMed ID: 35434999)
1. Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype-Positive.
Castrini AI; Skjølsvik E; Estensen ME; Almaas VM; Skulstad H; Lyseggen E; Edvardsen T; Lie ØH; Picard KCI; Lakdawala NK; Haugaa KH
J Am Heart Assoc; 2022 Apr; 11(8):e024960. PubMed ID: 35434999
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
[TBL] [Abstract][Full Text] [Related]
3. Timing of cardioverter-defibrillator implantation in patients with cardiac laminopathies-External validation of the LMNA-risk ventricular tachyarrhythmia calculator.
Rootwelt-Norberg C; Christensen AH; Skjølsvik ET; Chivulescu M; Vissing CR; Bundgaard H; Aabel EW; Bogsrud MP; Hasselberg NE; Lie ØH; Haugaa KH
Heart Rhythm; 2023 Mar; 20(3):423-429. PubMed ID: 36494026
[TBL] [Abstract][Full Text] [Related]
4. Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study.
Rootwelt-Norberg C; Skjølsvik ET; Chivulescu M; Bogsrud MP; Ribe MP; Aabel EW; Beitnes JO; Brekke PH; Håland TF; Hasselberg NE; Lie ØH; Haugaa KH
Europace; 2023 Feb; 25(2):634-642. PubMed ID: 36352512
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in
Tremblay-Gravel M; Ichimura K; Picard K; Kawano Y; Dries AM; Haddad F; Lakdawala NK; Wheeler MT; Parikh VN
Circ Genom Precis Med; 2023 Feb; 16(1):e003480. PubMed ID: 36548481
[TBL] [Abstract][Full Text] [Related]
6. Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study.
Peretto G; Barison A; Forleo C; Di Resta C; Esposito A; Aquaro GD; Scardapane A; Palmisano A; Emdin M; Resta N; Santoni A; Guaricci AI; Santobuono VE; Pepe M; Favale S; Ferrari M; Benedetti S; Della Bella P; Sala S
Europace; 2020 Dec; 22(12):1864-1872. PubMed ID: 32995851
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.
Kumar S; Baldinger SH; Gandjbakhch E; Maury P; Sellal JM; Androulakis AF; Waintraub X; Charron P; Rollin A; Richard P; Stevenson WG; Macintyre CJ; Ho CY; Thompson T; Vohra JK; Kalman JM; Zeppenfeld K; Sacher F; Tedrow UB; Lakdawala NK
J Am Coll Cardiol; 2016 Nov; 68(21):2299-2307. PubMed ID: 27884249
[TBL] [Abstract][Full Text] [Related]
8. The response to cardiac resynchronization therapy in LMNA cardiomyopathy.
Sidhu K; Castrini AI; Parikh V; Reza N; Owens A; Tremblay-Gravel M; Wheeler MT; Mestroni L; Taylor M; Graw S; Gigli M; Merlo M; Paldino A; Sinagra G; Judge DP; Ramos H; Mesubi O; Brown E; Turnbull S; Kumar S; Roy D; Tedrow UB; Ngo L; Haugaa K; Lakdawala NK
Eur J Heart Fail; 2022 Apr; 24(4):685-693. PubMed ID: 35229420
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).
van Dongen IM; Yilmaz D; Elias J; Claessen BEPM; Delewi R; Knops RE; Wilde AAM; van Erven L; Schalij MJ; Henriques JPS
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720502
[TBL] [Abstract][Full Text] [Related]
10. Gene-Based Risk Stratification for Cardiac Disorders in
Nishiuchi S; Makiyama T; Aiba T; Nakajima K; Hirose S; Kohjitani H; Yamamoto Y; Harita T; Hayano M; Wuriyanghai Y; Chen J; Sasaki K; Yagihara N; Ishikawa T; Onoue K; Murakoshi N; Watanabe I; Ohkubo K; Watanabe H; Ohno S; Doi T; Shizuta S; Minamino T; Saito Y; Oginosawa Y; Nogami A; Aonuma K; Kusano K; Makita N; Shimizu W; Horie M; Kimura T
Circ Cardiovasc Genet; 2017 Dec; 10(6):. PubMed ID: 29237675
[TBL] [Abstract][Full Text] [Related]
11. Lamin A/C gene mutations in familial cardiomyopathy with advanced atrioventricular block and arrhythmia.
Saga A; Karibe A; Otomo J; Iwabuchi K; Takahashi T; Kanno H; Kikuchi J; Keitoku M; Shinozaki T; Shimokawa H
Tohoku J Exp Med; 2009 Aug; 218(4):309-16. PubMed ID: 19638735
[TBL] [Abstract][Full Text] [Related]
12. Lamin A/C cardiomyopathy presenting as high-grade atrioventricular (AV) block, atrial fibrillation, heart failure and ventricular tachycardia in a single-family cluster.
Lubin SR; Paulraj S; Ahmed J
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37348923
[TBL] [Abstract][Full Text] [Related]
13. Novel c.367_369del LMNA mutation manifesting as severe arrhythmias, dilated cardiomyopathy, and myopathy.
Keller H; Finsterer J; Steger C; Wexberg P; Gatterer E; Khazen C; Stix G; Gerull B; Höftberger R; Weidinger F
Heart Lung; 2012; 41(4):382-6. PubMed ID: 22019351
[TBL] [Abstract][Full Text] [Related]
14. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.
Hasselberg NE; Haland TF; Saberniak J; Brekke PH; Berge KE; Leren TP; Edvardsen T; Haugaa KH
Eur Heart J; 2018 Mar; 39(10):853-860. PubMed ID: 29095976
[TBL] [Abstract][Full Text] [Related]
15. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
16. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
[TBL] [Abstract][Full Text] [Related]
17. A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family.
Glöcklhofer CR; Steinfurt J; Franke G; Hoppmann A; Glantschnig T; Perez-Feliz S; Alter S; Fischer J; Brunner M; Rainer PP; Köttgen A; Bode C; Odening KE
Europace; 2018 Dec; 20(12):2003-2013. PubMed ID: 29947763
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy.
Peretto G; Di Resta C; Perversi J; Forleo C; Maggi L; Politano L; Barison A; Previtali SC; Carboni N; Brun F; Pegoraro E; D'Amico A; Rodolico C; Magri F; Manzi RC; Palladino A; Isola F; Gigli L; Mongini TE; Semplicini C; Calore C; Ricci G; Comi GP; Ruggiero L; Bertini E; Bonomo P; Nigro G; Resta N; Emdin M; Favale S; Siciliano G; Santoro L; Sinagra G; Limongelli G; Ambrosi A; Ferrari M; Golzio PG; Bella PD; Benedetti S; Sala S;
Ann Intern Med; 2019 Oct; 171(7):458-463. PubMed ID: 31476771
[TBL] [Abstract][Full Text] [Related]
19. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator.
Koene RJ; Menon V; Cantillon DJ; Dresing TJ; Martin DO; Kanj M; Saliba WI; Tarakji KG; Baranowski B; Hussein AA; Tchou PJ; Bhargava M; Callahan TD; Rickard JW; Niebauer MJ; Chung MK; Varma N; Wilkoff BL; Lindsay BD; Wazni OM
Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e008168. PubMed ID: 32538135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
